Cargando…
Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children
The atypical antipsychotic risperidone (RSP) is often associated with weight gain and cardiometabolic side effects. The mechanisms for these adverse events are poorly understood and, undoubtedly, multifactorial in etiology. In light of growing evidence implicating the gut microbiome in the host'...
Autores principales: | Bahr, S M, Tyler, B C, Wooldridge, N, Butcher, B D, Burns, T L, Teesch, L M, Oltman, C L, Azcarate-Peril, M A, Kirby, J R, Calarge, C A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930121/ https://www.ncbi.nlm.nih.gov/pubmed/26440540 http://dx.doi.org/10.1038/tp.2015.135 |
Ejemplares similares
-
Correlates of weight gain during long-term risperidone treatment in children and adolescents
por: Calarge, Chadi Albert, et al.
Publicado: (2012) -
759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment
por: del Castillo, Nicole, et al.
Publicado: (2013) -
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies
por: Nurmi, E L, et al.
Publicado: (2013) -
The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain
por: Li, Li, et al.
Publicado: (2021) -
Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure
por: Bahr, Sarah M., et al.
Publicado: (2015)